Author Profile

Brian O'Flynn, PhD

Brian O'Flynn, PhD

Scientific Writer

Brian O’Flynn, PhD, is a Scientific Writer in the Strategic Communications, Education and Outreach Department at St. Jude.

Stories by Brian O'Flynn

Research

The long and the short of the cell antenna

Brian O'Flynn, PhD

Explore the pathway linking Sonic Hedgehog signaling with cilium length

Research

Exploring biomolecular condensate networks’ internal structure

Brian O'Flynn, PhD

See how molecular dynamics revealed the inhomogeneous nature of biomolecular condensates

Clinical

Uncovering the source of a “silent” syndrome

Brian O'Flynn, PhD

Discover the neuronal interactions at the center of posterior fossa syndrome

Investigator Insights

5 Questions for J. Paul Taylor, MD, PhD

J. Paul Taylor, MD, PhD and Brian O'Flynn, PhD and Kristin Stephenson, MHA, JD

Learn how J. Paul Taylor, MD, PhD, leveraged the unique infrastructure at St. Jude to launch the Pediatric Translational Neuroscience Initiative

Research

A glimpse beyond life and death: Exploring the biology of the MICOS complex

Brian O'Flynn, PhD

See how new model offers glimpse into vital mitochondrial complex

St. Jude On

Addressing the needs of childhood cancer survivors

Brian O'Flynn, PhD

See how many factors from environment to genetics affect the post-treatment experience of childhood cancer survivors

Research

Blazing a TRAIL in acute myeloid leukemia treatment

Brian O'Flynn, PhD

See how studies into AML drug reveals new potential target

Research

Study reveals the neurochemical gatekeeper to learning and the key to unlocking it

Brian O'Flynn, PhD

St. Jude research uncovers neural secrets behind our capacity to learn

Research

Drug which blocks stress granule formation offers insight into biomolecular condensates

Brian O'Flynn, PhD

See how G3BP inhibitors represent turning point in RNP granule research

Research

Following the breadcrumbs: Gain-of-function mutation leads researchers to new therapeutic target for pediatric AML

Brian O'Flynn, PhD

Explore the mechanistic insights behind novel pediatric AML therapeutic target